MedicationAgreement-v1.0.1(2017EN): verschil tussen versies

Huidige versie van 24 dec 2018 om 12:04

Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.zorg.MedicationAgreement
Version: 1.0.1
HCIM Status:Final
Release: 2017
Release status: Published
Release date: 31-12-2017

Back to HCIM list

Metadata

DCM::CoderList	Projectgroep Medicatieproces
DCM::ContactInformation.Address
DCM::ContactInformation.Name	*
DCM::ContactInformation.Telecom
DCM::ContentAuthorList	Projectgroep Medicatieproces
DCM::CreationDate	1-2-2017
DCM::DeprecatedDate
DCM::DescriptionLanguage	nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name	PM
DCM::EndorsingAuthority.Telecom
DCM::Id	2.16.840.1.113883.2.4.3.11.60.40.3.9.6
DCM::KeywordList	Medicatie, Afspraak
DCM::LifecycleStatus	Final
DCM::ModelerList	Kerngroep Registratie aan de Bron
DCM::Name	nl.zorg.Medicatieafspraak
DCM::PublicationDate	31-12-2017
DCM::PublicationStatus	Published
DCM::ReviewerList	Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
DCM::RevisionDate	31-12-2017
DCM::Superseeds	nl.zorg.Medicatieafspraak-v1.0
DCM::Version	1.0.1
HCIM::PublicationLanguage	EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (04-09-2017)

Publicatieversie 1.0.1 (31-12-2017)

ZIB-618	Hernoemen Verstrekking naar Medicatieverstrekking
ZIB-643	Kleine tekstuele verbeteringen

Concept

A medication agreement is a prescriber’s proposal for a patient to use medication. An agreement to discontinue the use of medication is also a medication agreement.

Purpose

The goal of the medication agreement is to provide insight into the agreements reached between the prescriber and the patient on the use of medication.

Information Model

MedicationAgreement-v1.0.1Model(2017EN).png

Type

Id

Concept

Card.

Definition

DefinitionCode

Reference

NL-CM:9.6.9580

MedicationAgreement

Root concept of the MedicationAgreement information model. This root concept contains all data elements of the MedicationAgreement information model.

NL-CM:9.6.1030

Prescriber::HealthProfessional

0..1

The health professional that entered the medication agreement with the patient.

HealthProfessional

NL-CM:9.6.23133

PrescriptionReason::Problem

0..1

The medical reason for the prescription or for use of the medication. This can be used to enter a medical indication which was the direct cause for prescription or for use of the medication in question.

It can concern every type of problem (or condition) of the patient, almost all diagnoses, complaints or symptoms.

Please note: The BST401T file of the G standard contains a “special reference” to indicate that “exchange of the reason for prescription is essential”.

Problem

NL-CM:9.6.23028

BodyWeight

0..1

Weight the dose is based on, relevant to this agreement.

BodyWeight

NL-CM:9.6.23023

BodyHeight

0..1

Height the dose is based on, relevant to this agreement.

BodyHeight

NL-CM:9.6.19925

AgreedMedicine::FarmaceuticalProduct

1

The medicine agreed upon to be used.

PharmaceuticalProduct

NL-CM:9.6.23240

InstructionsForUse

0..1

Instructions for the use of the medication, e.g. dose and route of administration.

InstructionsForUse

NL-CM:9.6.19757

MedicationAgreementDateTime

1

The time at which the agreement was made.

Appointment date + time are required (order of the appointments must be clear in cases with multiple appointments on one day)

NL-CM:9.6.19936

PeriodOfUse

0..1

Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original medication agreement. The end date indicates from when the medication is to be discontinued.

Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.

End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.

With medication for an indefinite period only a start date is indicated.

TimeInterval

NL-CM:9.6.23033

CanceledIndicator

0..1

In the event of an error correction of the medication agreement, this indicator is to be put on for the incorrect agreement.

NL-CM:9.6.19954

MedicationAgreementStopType

0..1

Stop type, the manner in which this medication is discontinued (temporary or definitive).

MedicationAgreementStopTypeCodeList

NL-CM:9.6.22094

ReasonMedicationAgreement

0..1

Reason for this agreement. This can be the reason to start, change or stop the medication treatment.

MedicationAgreementReasonCodeList

NL-CM:9.6.23283

MedicationAgreementAdditionalInformation

0..*

Additional information includes details on the structure of the agreement made that are relevant for pharmacovigilance and fulfillment by the pharmacist. This can be used e.g. to indicate that there was a conscious decision to deviate from the norm or that the agreement is to be structured in a certain way.

See also the Instructions section for more information about use of the element.

MedicationAgreementAdditionalInformationCodeList

NL-CM:9.6.22273

Comment

0..1

Comments regarding to the medication agreement. For example: in consultation with the medical specialist.

48767-8 Annotation comment

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page

Example Instances

Only available in Dutch

MedicatieAfspraak DatumTijd	Gebruiksperiode			Afgesproken geneesmiddel	Voorschrijver	Geannuleerd Indicator	MedicatieAfspraak Stoptype	MedicatieAfspraak.Reden
	Ingangsdatum	Einddatum	Duur	FarmaceutischProduct	Zorgverlener
					Naamgegevens
18-9-2016 18:00:00	08-09-16	18-09-16		Lisinopril tablet 10mg	D. Bakker	Nee	Definitief	Geen of onvoldoende effect
6-3-2016 9:12:30	06-03-2016			Methotrexaat injvlst 25mg/ml 0,6 ml	R. Jansen	Nee		Starten medicamenteuze behandeling

RedenVan Voorschrijven	Gebruiksinstructie
Probleem	Omschrijving	Doseerinstructie
		Doseerduur	Dosering \|Keerdosis	Toedieningsschema \|Frequentie \|Interval \|Toedientijd \|Weekdag \|Dagdeel
	Van 8-9-2017 tot 18-9-2017 1x per dag 1 stuk. Vanaf 18-9-2017 staken.		1 stuk	1x per dag
Reumatoïde Artritis	Vanaf 6 maart 2016 1x per week op maandag om 14uur 15 mg (=0,6 ml)		15 mg (=0,6 ml)	1x per week op maandag (14u)

Instructions

MedicationAgreementAdditionalInformation: When choosing a medicine, you can deviate from what is expected or from what the standard is. For example, when the hospital uses a different formulary than the community pharmacy. For reasons of efficiency, for example, one gastric acid inhibitor has been chosen in the hospital: pantoprazole.
Upon admission, a patient with omeprazole is converted to pantoprazole for the duration of the stay. When discharged, the patient goes back to omeprazole.
It is clear that something can go wrong here and that the patient takes both omeprazole and pantoprazole when there is no intervention. In the hospital's medication agreement for pantoprazole a remark can be made about the deviation so that it is clear that pantoprazole is the substitute for omeprazole or that it should be used in addition to omeprazole.
Another example are the half strengths. The hospital sometimes stocks tablets with half the strength of the normal trade preparation (own production). Where the patient enters the hospital on 25 mg chlortalidone, half a tablet once a day, he receives 12.5 mg intramural chlortalidone, one tablet once a day. Then the nursing does not have to break tablets in this case. Here there is a risk that the patient will use the 25 mg again at home, but then a whole tablet at a time in stead of half a tablet. By means of an explanation in the medication agreement (Additional information) of the last chlortalidone 25 mg, it can be indicated whether this has been a intended increase.

Valuesets

MedicationAgreementAdditionalInformationCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.3	Binding:

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Bewust hoge dosering	1	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Bewust hoge dosering
Bewust lage dosering	2	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Bewust lage dosering
Bewust afwijkende toedieningsweg	3	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Bewust afwijkende toedieningsweg
Medische noodzaak	4	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Medische noodzaak
Profylaxe	5	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Profylaxe
Wijziging in GDS per direct	6	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Wijziging in GDS per direct
Wijziging in GDS per rolwissel	7	Voorlopige G-std thesaurus 2050	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050	Wijziging in GDS per rolwissel

MedicationAgreementReasonCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2	Binding:

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Medication commenced (finding)	266709005	SNOMED CT	2.16.840.1.113883.6.96	Starten medicamenteuze behandeling
Administration of drug or medicament contraindicated (situation)	438833006	SNOMED CT	2.16.840.1.113883.6.96	Contra-indicatie
Drug interaction (disorder)	79899007	SNOMED CT	2.16.840.1.113883.6.96	Interactie
Hypersensitivity condition (disorder)	473010000	SNOMED CT	2.16.840.1.113883.6.96	Overgevoeligheid
Geen of onvoldoende effect	5	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Geen of onvoldoende effect
Te sterk effect	6	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Te sterk effect
(Mogelijke) bijwerking	7	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	(Mogelijke) bijwerking
Toedieningsweg voldoet niet	8	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Toedieningsweg voldoet niet
Indicatie vervallen	9	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Indicatie vervallen
Beleidswijziging	10	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Beleidswijziging
Admission to establishment (procedure)	305335007	SNOMED CT	2.16.840.1.113883.6.96	Opname
Wens patiënt	12	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Wens patiënt
Volgens afspraak	13	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Volgens afspraak
Hervatten beleid vorige voorschrijver	14	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Hervatten beleid vorige voorschrijver
Geplande procedure	15	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc.
Overig	OTH	NullFlavour	2.16.840.1.113883.5.1008	Overig

MedicationAgreementStopTypeCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.1	Binding:

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Tijdelijk	1	StopType	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1	Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
Definitief	2	StopType	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1	Het staken van een bestaande medicamenteuze behandeling.

This information model in other releases

Information model references

This information model refers to

This information model is used in

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR

Downloads

This information model is also available as pdf file or as spreadsheet

About this information

The information in this wikipage is based on Release 2017
Conditions for use are located on the mainpage
This page is generated on 21/12/2018 14:10:24 with ZibExtraction v. 3.0.6929.24609

Back to HCIM list

@@ Regel 1: / Regel 1: @@
-==General information==
+<!-- Hieronder wordt een transclude page aangeroepen -->
-Name: '''nl.zorg.MedicationAgreement''' [[Bestand:NL.png|link=Medicatieafspraak-v1.0.1(2017NL)]]<BR>
+{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.6(EN)|1|MedicationAgreement-v1.0.1(2017EN)}}
-Version: '''1.0.1''' <br>
+<!-- Tot hier de transclude page -->
-HCIM Status:Final<br>
+==General information<!--hdGeneralInformation-->==
-Release: '''2017''' <br>
+Name<!--hdName-->: '''nl.zorg.MedicationAgreement''' [[Bestand:NL.png|link=Medicatieafspraak-v1.0.1(2017NL)]]<BR>
-Release status: Published<br>
+Version<!--hdVersion-->: '''1.0.1''' <br>
-Release date: 31-12-2017
+HCIM Status<!--hdStatus-->:Final<br>
+Release<!--hdPublication-->: '''2017''' <br>
+Release status<!--hdPublicationStatus-->: Published<br>
+Release date<!--hdPublicationDate-->: 31-12-2017
 -----
-<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
+<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>
 ==Metadata==
@@ Regel 61: / Regel 64: @@
 ==Revision History==
 <div class="mw-collapsible mw-collapsed">
-''Only available in Dutch''
+''Only available in Dutch<!--noTranslation-->''
 <u>Publicatieversie 1.0</u> (04-09-2017)
@@ Regel 84: / Regel 87: @@
 ==Information Model==
 <BR>
-<imagemap> Bestand:MedicationAgreement-v1.0.1Model(EN).png | center
+<imagemap> Bestand:MedicationAgreement-v1.0.1Model(2017EN).png | center
-rect 283 540 557 590 [[#MedicationAgreementAdditionalInformationCodeList]]
+rect 293 548 567 598 [[#MedicationAgreementAdditionalInformationCodeList]]
-rect 352 445 562 515 [[#13304]]
+rect 362 453 572 523 [[#13304]]
-rect 170 69 312 139 [[Problem-v4.1(2017EN)]]
+rect 180 77 322 147 [[Problem-v4.1(2017EN)]]
-rect 775 196 917 263 [[PharmaceuticalProduct-v2.0(2017EN)]]
+rect 785 204 927 271 [[PharmaceuticalProduct-v2.0(2017EN)]]
-rect 771 541 981 590 [[#MedicationAgreementStopTypeCodeList]]
+rect 781 549 991 598 [[#MedicationAgreementStopTypeCodeList]]
-rect 567 540 761 590 [[#MedicationAgreementReasonCodeList]]
+rect 577 548 771 598 [[#MedicationAgreementReasonCodeList]]
-rect 333 68 453 135 [[HealthProfessional-v3.2(2017EN)]]
+rect 343 76 463 143 [[HealthProfessional-v3.2(2017EN)]]
-rect 474 69 594 136 [[BodyWeight-v3.1(2017EN)]]
+rect 484 77 604 144 [[BodyWeight-v3.1(2017EN)]]
-rect 615 69 757 136 [[BodyHeight-v3.1(2017EN)]]
+rect 625 77 767 144 [[BodyHeight-v3.1(2017EN)]]
-rect 777 320 919 387 [[#13318]]
+rect 787 328 929 395 [[#13318]]
-rect 597 445 739 515 [[#13305]]
+rect 607 453 749 523 [[#13305]]
-rect 774 444 916 511 [[#13314]]
+rect 784 452 926 519 [[#13314]]
-rect 174 319 322 389 [[#13306]]
+rect 184 327 332 397 [[#13306]]
-rect 169 445 317 515 [[TimeInterval-v1.0(2017EN)]]
+rect 179 453 327 523 [[TimeInterval-v1.0(2017EN)]]
-rect 776 72 918 139 [[InstructionsForUse-v1.1(2017EN)]]
+rect 786 80 928 147 [[InstructionsForUse-v1.1(2017EN)]]
-rect 170 195 318 263 [[#13312]]
+rect 180 203 328 271 [[#13312]]
-rect 468 253 606 320 [[#13317]]
+rect 478 261 616 328 [[#13317]]
 desc none
 </imagemap>
@@ Regel 107: / Regel 110: @@
 {| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
 |-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
-|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
+|style="width:30px;"|Type<!--imType-->||style="width:100px;"|Id<!--imId-->||colspan="6 " style="width:140px;"|Concept<!--imConcept-->||Card.<!--imCard-->||style="width: 600px;"|Definition<!--imDefinition-->||style="width:200px;"|DefinitionCode<!--imDefinitionCode-->||style="width:200px;"|Reference<!--imReference-->
 |-style="vertical-align:top; background-color: #E3E3E3; "
 |style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
@@ Regel 288: / Regel 291: @@
 {|
 |-
-|<span Title="Codesystem: LOINC"> 48767-8 Annotation comment</span>
+|<span title = "Codesystem: LOINC>[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment</span>
 |}
 |
 |}
-Columns Concept and DefinitionCode: hover over the values for more information<BR>
+Columns Concept and DefinitionCode: hover over the values for more information<!--imHover--><BR>
-For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]
+For explanation of the symbols, please see the legend page<!--imLegend--> [[Bestand:list2.png|link=Legend<!--wikiLegend-->]]
 ==Example Instances==
-''Only available in Dutch''
+''Only available in Dutch<!--noTranslation-->''
 {|class="wikitable" width="1202px" style= "font-size: 9.5pt;"
@@ Regel 388: / Regel 391: @@
 {| class="wikitable" width="60%"
 |-style='vertical-align:top; background-color: #E8D7BE;'
-|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.3
+|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.3
+|Binding<!--vsBindingTag-->:
 |}
 {| class="wikitable"  width="60% "
 |-style="background-color: #1F497D; color: white; font-weight: bold; "
-|Conceptname
+|Conceptname<!--vsConceptName-->
-|Conceptcode
+|Conceptcode<!--vsConceptCode-->
-|Codesystem name||Codesystem OID
+|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
-|Description
+|Description<!--vsDescription-->
 |-style="vertical-align:top; "
 |Bewust hoge dosering
@@ Regel 439: / Regel 443: @@
 |Wijziging in GDS per rolwissel
 |}
 === MedicationAgreementReasonCodeList===
 {| class="wikitable" width="60%"
 |-style='vertical-align:top; background-color: #E8D7BE;'
-|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2
+|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2
+|Binding<!--vsBindingTag-->:
 |}
 {| class="wikitable"  width="60% "
 |-style="background-color: #1F497D; color: white; font-weight: bold; "
-|Conceptname
+|Conceptname<!--vsConceptName-->
-|Conceptcode
+|Conceptcode<!--vsConceptCode-->
-|Codesystem name||Codesystem OID
+|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
-|Description
+|Description<!--vsDescription-->
 |-style="vertical-align:top; "
 |Medication commenced (finding)
-|266709005
+|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=266709005 266709005]
 |SNOMED CT
 |2.16.840.1.113883.6.96
@@ Regel 459: / Regel 463: @@
 |-style="vertical-align:top; "
 |Administration of drug or medicament contraindicated (situation)
-|438833006
+|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=438833006 438833006]
 |SNOMED CT
 |2.16.840.1.113883.6.96
@@ Regel 465: / Regel 469: @@
 |-style="vertical-align:top; "
 |Drug interaction (disorder)
-|79899007
+|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=79899007 79899007]
 |SNOMED CT
 |2.16.840.1.113883.6.96
@@ Regel 471: / Regel 475: @@
 |-style="vertical-align:top; "
 |Hypersensitivity condition (disorder)
-|473010000
+|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=473010000 473010000]
 |SNOMED CT
 |2.16.840.1.113883.6.96
@@ Regel 513: / Regel 517: @@
 |-style="vertical-align:top; "
 |Admission to establishment (procedure)
-|305335007
+|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=305335007 305335007]
 |SNOMED CT
 |2.16.840.1.113883.6.96
@@ Regel 548: / Regel 552: @@
 |Overig
 |}
 === MedicationAgreementStopTypeCodeList===
 {| class="wikitable" width="60%"
 |-style='vertical-align:top; background-color: #E8D7BE;'
-|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.1
+|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.1
+|Binding<!--vsBindingTag-->:
 |}
 {| class="wikitable"  width="60% "
 |-style="background-color: #1F497D; color: white; font-weight: bold; "
-|Conceptname
+|Conceptname<!--vsConceptName-->
-|Conceptcode
+|Conceptcode<!--vsConceptCode-->
-|Codesystem name||Codesystem OID
+|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
-|Description
+|Description<!--vsDescription-->
 |-style="vertical-align:top; "
 |Tijdelijk
@@ Regel 574: / Regel 578: @@
 |}
+==This information model in other releases<!--ftOtherReleases-->==
-==This information model in other releases==
+<!-- Hieronder wordt een transclude page aangeroepen -->
----
+{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.6(EN)|2|2017}}
-==More on this information model==
+<!-- Tot hier de transclude page -->
+==Information model references<!--ftReferences-->==
+====This information model refers to<!--ftRefersTo-->====
+*[[BodyHeight-v3.1(2017EN)|BodyHeight-v3.1]]
+*[[BodyWeight-v3.1(2017EN)|BodyWeight-v3.1]]
+*[[HealthProfessional-v3.2(2017EN)|HealthProfessional-v3.2]]
+*[[InstructionsForUse-v1.1(2017EN)|InstructionsForUse-v1.1]]
+*[[PharmaceuticalProduct-v2.0(2017EN)|PharmaceuticalProduct-v2.0]]
+*[[Problem-v4.1(2017EN)|Problem-v4.1]]
+*[[TimeInterval-v1.0(2017EN)|TimeInterval-v1.0]]
+====This information model is used in<!--ftReferredBy-->====
+*[[AdministrationAgreement-v1.0.1(2017EN)|AdministrationAgreement-v1.0.1]]
+*[[MedicationAdministration2-v1.0.1(2017EN)|MedicationAdministration2-v1.0.1]]
+==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
 To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
-Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
+Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
 <ul>
-<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.6&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
+<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.6&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
-<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=Profile [[File:fhir.png|link=]]]</li>
+<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2017}}</li>
 </ul>
-This information model is also available as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
+==Downloads<!--ftDownloadTitle-->==
-==About this information==
+This information model is also available as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]<!--ftDownloads-->
-The information in this wikipage is based on Release 2017 <BR>
+==About this information<!--ftHeader2-->==
-Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
+The information in this wikipage is based on<!--ftInfoBase--> Release 2017 <BR>
-This page is generated on 24/01/2018 15:58:01 <BR>
+Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
+This page is generated on 21/12/2018 14:10:24 with ZibExtraction v. 3.0.6929.24609<!--ftDate--> <BR>
 -----
-<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
+<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

MedicationAgreement-v1.0.1(2017EN): verschil tussen versies

Huidige versie van 24 dec 2018 om 12:04

Inhoud

General information

Metadata

Revision History

Concept

Purpose

Information Model

Example Instances

Instructions

Valuesets